日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Protocol of a randomised controlled phase II clinical trial investigating PREoperative endoscopic injection of BOTulinum toxin into the sphincter of Oddi to reduce bile leakage after hepatic resection: the PREBOT-II trial

一项随机对照 II 期临床试验方案，旨在研究术前内镜下向奥迪氏括约肌注射肉毒杆菌毒素以减少肝切除术后胆汁漏：PREBOT-II 试验

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2022-065727
Mack, Claudia Eva; Klaiber, Ulla; Sauer, Peter; Kohlhas, Laura; Baumann, Lukas; Martin, Eike; Mehrabi, Arianeb; Buchler, Markus W; Hackert, Thilo
发表日期：2023
文献求助 收藏

Protocol of a randomised controlled phase II clinical trial investigating PREoperative endoscopic injection of BOTulinum toxin into the sphincter of Oddi to reduce postoperative pancreatic fistula after distal pancreatectomy: the PREBOTPilot trial

一项随机对照 II 期临床试验方案，旨在研究术前内镜下向奥迪氏括约肌注射肉毒杆菌毒素以减少远端胰腺切除术后胰瘘的发生：PREBOTPilot 试验

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2020-036815
Klaiber, Ulla; Sauer, Peter; Martin, Eike; Bruckner, Thomas; Luntz, Steffen; Tjaden, Christine; Probst, Pascal; Knebel, Phillip; Diener, Markus K; Buchler, Markus W; Hackert, Thilo
发表日期：2020
文献求助 收藏

Methylglyoxal as a new biomarker in patients with septic shock: an observational clinical study.

甲基乙二醛作为脓毒症休克患者的新生物标志物：一项观察性临床研究

期刊:Critical Care
影响因子:9.3
doi:10.1186/s13054-014-0683-x
Brenner Thorsten, Fleming Thomas, Uhle Florian, Silaff Stephan, Schmitt Felix, Salgado Eduardo, Ulrich Alexis, Zimmermann Stefan, Bruckner Thomas, Martin Eike, Bierhaus Angelika, Nawroth Peter P, Weigand Markus A, Hofer Stefan
其它
发表日期：2014
文献求助 收藏

Reactive metabolites and AGE-RAGE-mediated inflammation in patients following liver transplantation

肝移植患者体内活性代谢物和AGE-RAGE介导的炎症

期刊:Mediators of Inflammation
影响因子:4.2
doi:10.1155/2013/501430
Brenner, Thorsten; Fleming, Thomas H; Spranz, David; Schemmer, Peter; Bruckner, Thomas; Uhle, Florian; Martin, Eike O; Weigand, Markus A; Hofer, Stefan
代谢
炎症/感染
RAGE
炎症
发表日期：2013
文献求助 收藏

L-arginine and asymmetric dimethylarginine are early predictors for survival in septic patients with acute liver failure

L-精氨酸和不对称二甲基精氨酸是脓毒症合并急性肝衰竭患者生存的早期预测因子。

期刊:Mediators of Inflammation
影响因子:4.2
doi:10.1155/2012/210454
Brenner, Thorsten; Fleming, Thomas H; Rosenhagen, Claudia; Krauser, Ute; Mieth, Markus; Bruckner, Thomas; Martin, Eike; Nawroth, Peter P; Weigand, Markus A; Bierhaus, Angelika; Hofer, Stefan
肝衰竭
败血症
毒理研究
炎症/感染
发表日期：2012
文献求助 收藏

Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction.

细胞死亡血清生物标志物是肝功能障碍重症脓毒症患者生存的早期预测指标

期刊:Critical Care
影响因子:9.3
doi:10.1186/cc7923
Hofer Stefan, Brenner Thorsten, Bopp Christian, Steppan Jochen, Lichtenstern Christoph, Weitz Jürgen, Bruckner Thomas, Martin Eike, Hoffmann Ursula, Weigand Markus A
细胞生物学
发表日期：2009
文献求助 收藏